|
January
Monday, Jan 30, 2012 FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma Friday, Jan 13, 2012 Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis December Wednesday, Dec 07, 2011 Genentech Announces Positive Results of Pivotal Phase III Study with Pertuzumab in HER2-Positive Metastatic Breast Cancer November Tuesday, Nov 29, 2011 Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium Friday, Nov 18, 2011 FDA Commissioner Announces Final Decision on Avastin for Metastatic Breast Cancer Tuesday, Nov 08, 2011 FDA Accepts Genentech's New Drug Application For Vismodegib in Advanced Form of Skin Cancer Saturday, Nov 05, 2011 Data Showed ACTEMRA Monotherapy Significantly Improved Signs and Symptoms of Rheumatoid Arthritis See the Archives
|
